BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Med-tech outlook 2026
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Saturday, May 9, 2026
Home » Topics » Briefs » Other news to note

Other news to note
Other news to note RSS Feed RSS

Other news to note for Nov. 3, 2023

Nov. 3, 2023
Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief: Astrazeneca, Kronos, Seres, Teva.
Read More

Other news to note for Nov. 3, 2023

Nov. 3, 2023
Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: Aerin Medical, Aplos, Cvrx, Element Biosciences, Myomo, Painteq, Qiagen, Quantalx, Surgical Information Sciences.
Read More

Other news to note for Nov. 2, 2023

Nov. 2, 2023
Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief: Abcellera, Bayer, Blue Water, Globestar, Jaguar, J&J, Locanabio, Kura, Mirati, Prelude, Protagonist, Quadri, Rani, Sangamo, Siren, Smi, Theriva, Tonix.
Read More

Other news to note for Nov. 2, 2023

Nov. 2, 2023
Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: Assure Holdings, Co-Diagnostics, Cryoport, Dupont, Eyenovia.
Read More

Other news to note for Nov. 2, 2023

Nov. 2, 2023
Additional early-stage research and drug discovery news in brief, from: Beyondspring, Citius Pharmaceuticals, Gri Bio, Maia Biotechnology.
Read More

Other news to note for Nov. 1, 2023

Nov. 1, 2023
Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief: 3Sbio, Abbvie, Aileron, Aldeyra, Apnimed, Atara, Cstone, Eli Lilly, Engene, Forbion, Generate, Inhalon, Kyverna, Ligand, Lung, Mei, Pierre Fabre, Reneo, Selecta, Shionogi, Sitryx, Sobi, Tolerance, Vtv.
Read More

Other news to note for Nov. 1, 2023

Nov. 1, 2023
Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: Embolx, Girlow, Medicom, Motus, Prenetics, Shuttle Pharmaceuticals.
Read More

Other news to note for Oct. 31, 2023

Oct. 31, 2023
Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief: Affamed, Alfasigma, Amgen, Arrowhead, Aug, Avalo, Basilea, Beam, Catalyst, Day One, Epicrispr, Galapagos, Genentech, GNI, GSK, J&J, Kite, Laverock, Paxmedica, Porosome, Roche, Shorla, Sosei, Therakind, Verge, Viracta, Xoma.
Read More

Other news to note for Oct. 31, 2023

Oct. 31, 2023
Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: Acuitymd, Body Vision, Cardio Diagnostics, Desktop Metal, Fabric Genomics, Geminiov, Guardant, Livsmed, Lucid Diagnostics, Microbot Medical, Orthoventions, Oxford Nanopore, Pavmed.
Read More

Other news to note for Oct. 31, 2023

Oct. 31, 2023
Biopharma happenings in Asia-Pacific, such as deals and partnerships, grants, preclinical data and other news in brief: Alphanavi, Anheart, Boehringer Ingelheim, Bristol Myers Squibb, Burning Rock, Immutep, Lianbio, Nippon Kayaku, Shanghai, Sumitomo Pharma.
Read More
Previous 1 2 … 142 143 144 145 146 147 148 149 150 … 1396 1397 Next

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for May 8, 2026.
  • News in brief

    BioWorld Asia
    BioWorld Asia briefs for May 5, 2026
  • Rendering of a key measles protein targeted by neutralizing human antibodies

    First measles treatment advances as vaccination rates drop

    BioWorld
    Scientists at the La Jolla Institute for Immunology have identified and characterized human antibodies that neutralize the measles virus by blocking its entry...
  • Close up of bow of cruise ship

    Hantavirus is ‘sentinel’ more than acute pandemic threat

    BioWorld
    News of eight infections and three deaths so far due to an emerging zoonotic virus has brought back unhappy memories of the early days of SARS-CoV-2. At a press...
  • Infensa Bioscience identifies new ASIC blockers

    BioWorld Science
    Infensa Bioscience Pty Ltd. has patented new acid-sensing ion channel 1 (ASIC) blockers potentially useful for the treatment of stroke, among others.
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing